(HealthDay)—For patients with refractory or relapsed peripheral T-cell lymphoma (R/R-PTCL), three- and five-year overall survival (OS) and progression-free survival (PFS) are similar with allogeneic or autologous […]
The antibodies we create after we’re infected with a virus or vaccinated against it can be very powerful. A virus typically spreads within our bodies by […]
Surgeons can ease their patients’ pain from common operations without prescribing opioids, and avoid the possibility of starting someone on a path to long-term use, a […]